Bumper Offer - Urjas oil Just @ Rs. 1
Razel A 75 Capsule is a prescription drug, available for use as Capsule. Other than this, Razel A 75 Capsule has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Razel A 75 Capsule. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Razel A 75 Capsule side effects, there are can be others also. These have been listed below. These side effects of Razel A 75 Capsule are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Razel A 75 Capsule has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Razel A 75 Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Razel A 75 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. Some other conditions that can be affected by Razel A 75 Capsule are listed in the contraindications section below.
Drug interactions for Razel A 75 Capsule have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Razel A 75 Capsule is safe while driving, and is addiction.
Razel A 75 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Razel A 75 Capsule is used -
Severe
Moderate
Mild
Is the use of Razel A 75 Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Razel A. If you are pregnant, do not take Razel A without a doctor's advice.
Is the use of Razel A 75 Capsule safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Razel A. It should only be taken after medical advice.
What is the effect of Razel A 75 Capsule on the Kidneys?
Razel A can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Razel A 75 Capsule on the Liver?
Using Razel A does not have any harmful effects on the liver.
What is the effect of Razel A 75 Capsule on the Heart?
Razel A can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Razel A 75 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Razel A 75 Capsule unless your doctor advises you to do so -
Is this Razel A 75 Capsule habit forming or addictive?
No, there is no any evidence that Razel A 75 Capsule is addictive.
Interaction between Food and Razel A 75 Capsule
There isn't any research available on the side effects of taking Razel A 75 Capsule with food.
Interaction between Alcohol and Razel A 75 Capsule
Information about the interaction of Razel A 75 Capsule and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
